chr1-103619721-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000699.4(AMY2A):c.681C>A(p.Asp227Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000447 in 151,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000699.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000448 AC: 68AN: 151844Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.0000481 AC: 6AN: 124652Hom.: 0 AF XY: 0.0000463 AC XY: 3AN XY: 64818
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000383 AC: 56AN: 1461300Hom.: 0 Cov.: 32 AF XY: 0.0000316 AC XY: 23AN XY: 726990
GnomAD4 genome AF: 0.000447 AC: 68AN: 151962Hom.: 0 Cov.: 27 AF XY: 0.000431 AC XY: 32AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 26, 2024 | The c.681C>A (p.D227E) alteration is located in exon 4 (coding exon 4) of the AMY2A gene. This alteration results from a C to A substitution at nucleotide position 681, causing the aspartic acid (D) at amino acid position 227 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at